Martínez-Gómez AR, Suárez-Lascano AB, Vivar-del Hoyo P, Del Castillo-Velilla I, Beraghi M, Torrente-Fernández MM, Palomo-Atance E, García-Cabezas MÁ

Language: Spanish
References: 14
Page: 28-33
PDF size: 150.43 Kb.

ABSTRACT

No abstract.

REFERENCES

1. M., Legac I., Vuillard E., Guibourdenche J., Castanet M., Luton D. Congenital hyperthyroidism: the fetus as a patient. Horm Res. 2006;65(5):235-242. DOI:10.1159/000092454.

2. Samuels S., Namoc S., Bauer A. Neonatal Thyrotoxicosis. MDcClinPerinatol. 2018;45:31–40. DOI: 10.1016/j.clp.2017.10.001.

3. Cooper D.S., Laurberg P. Hyperthyroidism in pregnancy. Lancet. Diabetes endocrinol. 2013;1(3):238-249. DOI: 10.1016/S2213-8587(13)70086-X.

4. Andersen S.L., Andersen S., Vestergaard P., Olsen J. Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a danish nationwide case-cohort study. Thyroid. 2018;28:537-546. DOI: 10.1089/thy.2017.0425

5. Moleti M., Di Mauro M., Sturniolo G. Russo M., Vermiglio F. Hyperthyroidism in the pregnant woman: Maternal and fetal aspects. JClinTransl. Endocrinol. 2019;16:100190. DOI:10.1016/j.jcte.2019.100190.

6. La Laguna P., Perales J.I., Congost S., Odriozola M., Vara M., Conde S., et al. Hipertiroidismo neonatal. Revista Española de Endocrinología Pediátrica. 2015;6(2), 89-93. DOI:10.3266/RevEspEndocrinolPediatr.pre2015.Jun.310

7. Levy-Shraga Y., Tamir-Hostovsky L., Boyko V., Lerner-Geva L., Pinhas-Hamiel O. Follow-up of newborns of mothers with Graves' disease. Thyroid. 2014;24(06):1032-1039. DOI: 10.1089/thy.2013.0489.

8. Van Dijk MM., Smits IH., Fliers E., Bisschop P. Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review. Thyroid. 2018;28(02):257-264. DOI: 10.1089/thy.2017.0413.

9. Cui Y., Rijhsinghani A. Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves`Disease for Predicting Perinatal Thyroid Dysfunction. AJP Rep. 2019Oct;9(4):341-345. DOI: 10.1055/s-0039-1694035.

10. Rivkees SA., Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J ClinEndocrinolMetab. 2010;95:3260. DOI: 10.1210/jc.2009-2546.

11. Tagami T., Yambe Y., Tanaka T., Tanaka T., Ogo A., Yoshizumi H., et al. Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease. InternMed. 2012;51:2285. DOI: 10.2169/internalmedicine.51.7302.

12. Takata K., Amino N., Kubota S., Sasaki I., Nishiharra E., Kudo T., et al. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. ClinEndocrinol (Oxf). 2010;72:845. DOI: 10.1111/j.1365-2265.2009.03745.x.

13. Higuchi R., Kumagai T., Kobayashi M., Minami T., Koyama H., Ishii Y. Short-Term Hyperthyroidism Followed by Transient Pituitary Hypothyroidism in a Very Low Birth Weight Infant Born to a Mother With Uncontrolled Graves Disease. Pediatrics. 2001;107:57. DOI:10.1542/peds.107.4.e57.

14. Kempers MJ., van Tijn DA., van Trotsenburg AS., de Vijlder J., Wiedijk B., Vulsma T. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. JClinEndocrinolMetab. 2003;88:5851. DOI: 10.1210/jc.2003-030665.